{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:03:36Z","timestamp":1740157416187,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s13105-023-00950-8","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:03:56Z","timestamp":1677143036000},"page":"415-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-9119","authenticated-orcid":false,"given":"Maria Carmen","family":"Iglesias-Osma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2552-5973","authenticated-orcid":false,"given":"Maria Jos\u00e9","family":"Garc\u00eda-Barrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-1978","authenticated-orcid":false,"given":"David","family":"Hernandez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5623-738X","authenticated-orcid":false,"given":"K\u00e9vin","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-4831","authenticated-orcid":false,"given":"P\u00e9n\u00e9lope","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7765-6647","authenticated-orcid":false,"given":"Christian","family":"Carp\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"950_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/schbul\/sbq053","volume":"38","author":"VL Albaugh","year":"2012","unstructured":"Albaugh VL, Vary TC, Ilkayeva O, Wenner BR, Maresca KP, Joyal JL, Breazeale S, Elich TD, Lang CH, Lynch CJ (2012) Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophr Bull 38:153\u2013166. https:\/\/doi.org\/10.1093\/schbul\/sbq053","journal-title":"Schizophr Bull"},{"key":"950_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1749-6632.1987.tb36212.x","volume":"499","author":"JG Bernstein","year":"1987","unstructured":"Bernstein JG (1987) Induction of obesity by psychotropic drugs. Ann N Y Acad Sci 499:203\u2013215","journal-title":"Ann N Y Acad Sci"},{"key":"950_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0014-2999(90)90260-d","volume":"177","author":"WD Bowen","year":"1990","unstructured":"Bowen WD, Moses EL, Tolentino PJ, Walker JM (1990) Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors. Eur J Pharmacol 177:111\u2013118. https:\/\/doi.org\/10.1016\/0014-2999(90)90260-d","journal-title":"Eur J Pharmacol"},{"key":"950_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00702-012-0951-3","volume":"120","author":"C Carp\u00e9n\u00e9","year":"2013","unstructured":"Carp\u00e9n\u00e9 C, Gr\u00e8s S, Rascalou S (2013) The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake. J Neural Transm (Vienna) 120:997\u20131003. https:\/\/doi.org\/10.1007\/s00702-012-0951-3","journal-title":"J Neural Transm (Vienna)"},{"key":"950_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s13105-018-0643-z","volume":"74","author":"C Carp\u00e9n\u00e9","year":"2018","unstructured":"Carp\u00e9n\u00e9 C, Galitzky J, Belles C, Zakaroff-Girard A (2018) Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in food. J Physiol Biochem 74:623\u2013633. https:\/\/doi.org\/10.1007\/s13105-018-0643-z","journal-title":"J Physiol Biochem"},{"key":"950_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/antiox8030074","volume":"8","author":"C Carp\u00e9n\u00e9","year":"2019","unstructured":"Carp\u00e9n\u00e9 C, Les F, Casedas G, Peiro C, Fontaine J, Chaplin A, Mercader J, Lopez V (2019) Resveratrol anti-obesity effects: rapid inhibition of adipocyte glucose utilization. Antioxidants (Basel) 8:74. https:\/\/doi.org\/10.3390\/antiox8030074","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"950_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/ph13030041","volume":"13","author":"C Carp\u00e9n\u00e9","year":"2020","unstructured":"Carp\u00e9n\u00e9 C, Les F, Mercader J, Gomez-Zorita S, Grolleau JL, Boulet N, Fontaine J, Iglesias-Osma MC, Garcia-Barrado MJ (2020) Opipramol inhibits lipolysis in human adipocytes without altering glucose uptake and differently from antipsychotic and antidepressant drugs with adverse effects on body weight control. Pharmaceuticals (Basel) 13(3):41. https:\/\/doi.org\/10.3390\/ph13030041","journal-title":"Pharmaceuticals (Basel)"},{"key":"950_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1476-5381.1977.tb08393.x","volume":"59","author":"SA Doggrell","year":"1977","unstructured":"Doggrell SA, Woodruff GN (1977) Effects of antidepressant drugs on noradrenaline accumulation and contractile responses in the rat anococcygeus muscle. Br J Pharmacol 59:403\u2013409. https:\/\/doi.org\/10.1111\/j.1476-5381.1977.tb08393.x","journal-title":"Br J Pharmacol"},{"key":"950_CR9","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1210\/endo-122-5-2285","volume":"122","author":"WC Duckworth","year":"1988","unstructured":"Duckworth WC, Solomon SS, Liepnieks J, Hamel FG, Hand S, Peavy DE (1988) Insulin-like effects of vanadate in isolated rat adipocytes. Endocrinology 122:2285\u20132289. https:\/\/doi.org\/10.1210\/endo-122-5-2285","journal-title":"Endocrinology"},{"key":"950_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/bf01222097","volume":"11","author":"JM Feldman","year":"1975","unstructured":"Feldman JM, Chapman B (1975) Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insulin secretion. Diabetologia 11:487\u2013494. https:\/\/doi.org\/10.1007\/bf01222097","journal-title":"Diabetologia"},{"key":"950_CR11","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/jci21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752\u20131761. https:\/\/doi.org\/10.1172\/jci21625","journal-title":"J Clin Invest"},{"key":"950_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/s-0043-100762","volume":"85","author":"M Gahr","year":"2017","unstructured":"Gahr M, Hiemke C, Connemann BJ (2017) Update Opipramol. Fortschr Neurol Psychiatr 85:139\u2013145. https:\/\/doi.org\/10.1055\/s-0043-100762","journal-title":"Fortschr Neurol Psychiatr"},{"key":"950_CR13","doi-asserted-by":"crossref","unstructured":"Garcia Barrado MJ, Pastor MF, Iglesias-Osma MC, Carp\u00e9n\u00e9 C, J. M (2010) Comparative effects of idazoxan, efaroxan, and BU 224 on insulin secretion in the rabbit: not only interaction with pancreatic imidazoline I2 binding sites. Health 2:112-123.","DOI":"10.4236\/health.2010.22018"},{"key":"950_CR14","doi-asserted-by":"publisher","first-page":"560006","DOI":"10.3389\/fpsyt.2020.560006","volume":"11","author":"C Garcia-Rizo","year":"2020","unstructured":"Garcia-Rizo C (2020) Antipsychotic-induced weight gain and clinical improvement: A psychiatric paradox. Front Psychiatry 11:560006. https:\/\/doi.org\/10.3389\/fpsyt.2020.560006","journal-title":"Front Psychiatry"},{"key":"950_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/en.2009-0996","volume":"151","author":"I Garc\u00eda-Tornad\u00fa","year":"2010","unstructured":"Garc\u00eda-Tornad\u00fa I, Ornstein AM, Chamson-Reig A, Wheeler MB, Hill DJ, Arany E, Rubinstein M, Becu-Villalobos D (2010) Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance. Endocrinology 151:1441\u20131450. https:\/\/doi.org\/10.1210\/en.2009-0996","journal-title":"Endocrinology"},{"key":"950_CR16","doi-asserted-by":"publisher","first-page":"e1001485","DOI":"10.1371\/journal.pbio.1001485","volume":"11","author":"A Girousse","year":"2013","unstructured":"Girousse A, Tavernier G, Valle C, Moro C, Mejhert N, Dinel AL, Houssier M, Roussel B, Besse-Patin A, Combes M, Mir L, Monbrun L, Bezaire V, Prunet-Marcassus B, Waget A, Vila I, Caspar-Bauguil S, Louche K, Marques MA et al (2013) Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass. PLoS Biol 11:e1001485. https:\/\/doi.org\/10.1371\/journal.pbio.1001485","journal-title":"PLoS Biol"},{"key":"950_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s13105-012-0229-0","volume":"69","author":"S Gomez-Zorita","year":"2013","unstructured":"Gomez-Zorita S, Treguer K, Mercader J, Carp\u00e9n\u00e9 C (2013) Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells. J Physiol Biochem 69:585\u2013593. https:\/\/doi.org\/10.1007\/s13105-012-0229-0","journal-title":"J Physiol Biochem"},{"issue":"13","key":"950_CR18","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.3390\/molecules26133831","volume":"26","author":"W Haj Ahmed","year":"2021","unstructured":"Haj Ahmed W, Boulet N, Briot A, Ryan BJ, Kinsella GK, O\u2019Sullivan J, Les F, Mercader-Barcel\u00f3 J, Henehan GTM, Carp\u00e9n\u00e9 C (2021) Novel facet of an old dietary molecule? Direct influence of caffeine on glucose and biogenic amine handling by human adipocytes. Molecules 26(13):3831. https:\/\/doi.org\/10.3390\/molecules26133831","journal-title":"Molecules"},{"key":"950_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s13105-014-0315-6","volume":"70","author":"I Harant-Farrugia","year":"2014","unstructured":"Harant-Farrugia I, Garcia J, Iglesias-Osma MC, Garcia-Barrado MJ, Carpene C (2014) Is there an optimal dose for dietary linoleic acid? Lessons from essential fatty acid deficiency supplementation and adipocyte functions in rats. J Physiol Biochem 70:615\u2013627. https:\/\/doi.org\/10.1007\/s13105-014-0315-6","journal-title":"J Physiol Biochem"},{"key":"950_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1042\/bj1960771","volume":"196","author":"JC Henquin","year":"1981","unstructured":"Henquin JC (1981) Effects of trifluoperazine and pimozide on stimulus-secretion coupling in pancreatic B-cells. Suggestion for a role of calmodulin? Biochem J 196:771\u2013780. https:\/\/doi.org\/10.1042\/bj1960771","journal-title":"Biochem J"},{"key":"950_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00702-003-0019-5","volume":"110","author":"G Holoubek","year":"2003","unstructured":"Holoubek G, M\u00fcller WE (2003) Specific modulation of sigma binding sites by the anxiolytic drug opipramol. J Neural Transm 110:1169\u20131179","journal-title":"J Neural Transm"},{"key":"950_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1124\/jpet.103.063636","volume":"309","author":"MC Iglesias-Osma","year":"2004","unstructured":"Iglesias-Osma MC, Garcia-Barrado MJ, Visentin V, Pastor-Mansilla MF, Bour S, Prevot D, Valet P, Moratinos J, Carp\u00e9n\u00e9 C (2004) Benzylamine exhibits insulin-like effects on glucose disposal, glucose transport, and fat cell lipolysis in rabbits and diabetic mice. J Pharmacol Exp Ther 309:1020\u20131028. https:\/\/doi.org\/10.1124\/jpet.103.063636","journal-title":"J Pharmacol Exp Ther"},{"key":"950_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1176\/ajp.156.2.312","volume":"156","author":"T Kraus","year":"1999","unstructured":"Kraus T, Haack M, Schuld A, Hinze-Selch D, K\u00fchn M, Uhr M, Pollm\u00e4cher T (1999) Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156:312\u2013314. https:\/\/doi.org\/10.1176\/ajp.156.2.312","journal-title":"Am J Psychiatry"},{"key":"950_CR24","first-page":"241","volume":"116","author":"Y Krausz","year":"1987","unstructured":"Krausz Y, Eylon L, Cerasi E (1987) Calcium-binding proteins and insulin release. Differential effects of phenothiazines on first- and second-phase secretion and on islet cAMP response to glucose. Acta Endocrinol (Copenh) 116:241\u2013246","journal-title":"Acta Endocrinol (Copenh)"},{"key":"950_CR25","doi-asserted-by":"publisher","first-page":"10135","DOI":"10.1074\/jbc.272.15.10135","volume":"272","author":"HI Krieger-Brauer","year":"1997","unstructured":"Krieger-Brauer HI, Medda PK, Kather H (1997) Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Galphai2. J Biol Chem 272:10135\u201310143","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"950_CR26","first-page":"S435","volume":"27","author":"K Krysta","year":"2015","unstructured":"Krysta K, Murawiec S, Warchala A, Zawada K, Cuba\u0142a WJ, Wiglusz MS, Jakuszkowiak-Wojten K, Krzystanek M, Krupka-Matuszczyk I (2015) Modern indications for the use of opipramol. Psychiatr Danub 27(Suppl 1):S435\u2013S437","journal-title":"Psychiatr Danub"},{"key":"950_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1517\/14740338.5.1.157","volume":"5","author":"RS McIntyre","year":"2006","unstructured":"McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH (2006) The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf 5:157\u2013168. https:\/\/doi.org\/10.1517\/14740338.5.1.157","journal-title":"Expert Opin Drug Saf"},{"key":"950_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/s0924-977x(01)00108-0","volume":"11","author":"K Melkersson","year":"2001","unstructured":"Melkersson K, Khan A, Hilding A, Hulting AL (2001) Different effects of antipsychotic drugs on insulin release in vitro. Eur Neuropsychopharmacol 11:327\u2013332. https:\/\/doi.org\/10.1016\/s0924-977x(01)00108-0","journal-title":"Eur Neuropsychopharmacol"},{"key":"950_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.2042-7158.1994.tb03801.x","volume":"46","author":"S Minder","year":"1994","unstructured":"Minder S, Daniel WA, Clausen J, Bickel MH (1994) Adipose tissue storage of drugs as a function of binding competition. In-vitro studies with distribution dialysis. J Pharm Pharmacol 46:313\u2013315. https:\/\/doi.org\/10.1111\/j.2042-7158.1994.tb03801.x","journal-title":"J Pharm Pharmacol"},{"key":"950_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/sj.mp.4001948","volume":"12","author":"J Minet-Ringuet","year":"2007","unstructured":"Minet-Ringuet J, Even PC, Valet P, Carp\u00e9n\u00e9 C, Visentin V, Prevot D, Daviaud D, Quignard-Boulange A, Tome D, de Beaurepaire R (2007) Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment. Mol Psychiatry 12:562\u2013571. https:\/\/doi.org\/10.1038\/sj.mp.4001948","journal-title":"Mol Psychiatry"},{"key":"950_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1037\/a0022258","volume":"19","author":"MJ Minzenberg","year":"2011","unstructured":"Minzenberg MJ, Yoon JH (2011) An index of relative central \u03b1-adrenergic receptor antagonism by antipsychotic medications. Exp Clin Psychopharmacol 19:31\u201339. https:\/\/doi.org\/10.1037\/a0022258","journal-title":"Exp Clin Psychopharmacol"},{"key":"950_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00004714-200102000-00011","volume":"21","author":"HJ M\u00f6ller","year":"2001","unstructured":"M\u00f6ller HJ, Volz HP, Reimann IW, Stoll KD (2001) Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. J Clin Psychopharmacol 21:59\u201365. https:\/\/doi.org\/10.1097\/00004714-200102000-00011","journal-title":"J Clin Psychopharmacol"},{"key":"950_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/s-0028-1093895","volume":"6","author":"AJ Moody","year":"1974","unstructured":"Moody AJ, Stan MA, Stan M, Gliemann J (1974) A simple free fat cell bioassay for insulin. Horm Metab Res 6:12\u201316. https:\/\/doi.org\/10.1055\/s-0028-1093895","journal-title":"Horm Metab Res"},{"key":"950_CR34","doi-asserted-by":"publisher","first-page":"36380","DOI":"10.1074\/jbc.M213032200","volume":"278","author":"H Mulder","year":"2003","unstructured":"Mulder H, S\u00f6rhede-Winzell M, Contreras JA, Fex M, Str\u00f6m K, Ploug T, Galbo H, Arner P, Lundberg C, Sundler F, Ahr\u00e9n B, Holm C (2003) Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 278:36380\u201336388. https:\/\/doi.org\/10.1074\/jbc.M213032200","journal-title":"J Biol Chem"},{"issue":"Suppl 3","key":"950_CR35","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1055\/s-2004-832677","volume":"37","author":"WE M\u00fcller","year":"2004","unstructured":"M\u00fcller WE, Siebert B, Holoubek G, Gentsch C (2004) Neuropharmacology of the anxiolytic drug opipramol, a sigma site ligand. Pharmacopsychiatry 37(Suppl 3):S189\u2013S197. https:\/\/doi.org\/10.1055\/s-2004-832677","journal-title":"Pharmacopsychiatry"},{"key":"950_CR36","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.bbrc.2015.10.045","volume":"467","author":"S Nimura","year":"2015","unstructured":"Nimura S, Yamaguchi T, Ueda K, Kadokura K, Aiuchi T, Kato R, Obama T, Itabe H (2015) Olanzapine promotes the accumulation of lipid droplets and the expression of multiple perilipins in human adipocytes. Biochem Biophys Res Commun 467:906\u2013912. https:\/\/doi.org\/10.1016\/j.bbrc.2015.10.045","journal-title":"Biochem Biophys Res Commun"},{"key":"950_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s2215-0366(19)30416-x","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, Beck K, Natesan S, Efthimiou O, Cipriani A, Howes OD (2020) Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry 7:64\u201377. https:\/\/doi.org\/10.1016\/s2215-0366(19)30416-x","journal-title":"Lancet Psychiatry"},{"key":"950_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/wnf.0000000000000332","volume":"42","author":"V Rozanski","year":"2019","unstructured":"Rozanski V, Laux G, Schwarz J (2019) The dopamine receptor antagonism of opipramol: relevance to Parkinsonism? Clin Neuropharmacol 42:77\u201379. https:\/\/doi.org\/10.1097\/wnf.0000000000000332","journal-title":"Clin Neuropharmacol"},{"key":"950_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/bf00258316","volume":"19","author":"E Samols","year":"1980","unstructured":"Samols E, Stagner JI (1980) Reinterpretation of the effect of haloperidol and ethanol on insulin secretion. Diabetologia 19:81\u201383. https:\/\/doi.org\/10.1007\/bf00258316","journal-title":"Diabetologia"},{"key":"950_CR40","doi-asserted-by":"publisher","first-page":"104445","DOI":"10.1016\/j.psyneuen.2019.104445","volume":"110","author":"A Sarsenbayeva","year":"2019","unstructured":"Sarsenbayeva A, Marques-Santos CM, Thombare K, Di Nunzio G, Almby KE, Lundqvist M, Eriksson JW, Pereira MJ (2019) Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism. Psychoneuroendocrinol 110:104445\u2013104445. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104445","journal-title":"Psychoneuroendocrinol"},{"key":"950_CR41","first-page":"447","volume":"58","author":"M Schulz","year":"2003","unstructured":"Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58:447\u2013474","journal-title":"Pharmazie"},{"key":"950_CR42","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.pnpbp.2011.07.017","volume":"35","author":"AL Serti\u00e9","year":"2011","unstructured":"Serti\u00e9 AL, Suzuki AM, Serti\u00e9 RAL, Andreotti S, Lima FB, Passos-Bueno MR, Gattaz WF (2011) Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism. Prog Neuropsychopharmacol Biol Psychiatry 35:1884\u20131890. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.07.017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"950_CR43","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2337\/diab.44.8.863","volume":"44","author":"RH Unger","year":"1995","unstructured":"Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863\u2013870. https:\/\/doi.org\/10.2337\/diab.44.8.863","journal-title":"Genetic and clinical implications. Diabetes"},{"key":"950_CR44","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.npp.1301142","volume":"32","author":"HS Vestri","year":"2007","unstructured":"Vestri HS, Maianu L, Moellering DR, Garvey WT (2007) Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacology 32:765\u2013772. https:\/\/doi.org\/10.1038\/sj.npp.1301142","journal-title":"Neuropsychopharmacology"},{"key":"950_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/jc.2008-1815","volume":"95","author":"S Vidarsdottir","year":"2010","unstructured":"Vidarsdottir S, de Leeuw van Weenen JE, Fr\u00f6lich M, Roelfsema F, Romijn JA, Pijl H (2010) Effects of olanzapine and haloperidol on the metabolic status of healthy men. J Clin Endocrinol Metab 95:118\u2013125. https:\/\/doi.org\/10.1210\/jc.2008-1815","journal-title":"J Clin Endocrinol Metab"},{"key":"950_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/oby.2001.15","volume":"9","author":"SP Wang","year":"2001","unstructured":"Wang SP, Laurin N, Himms-Hagen J, Rudnicki MA, Levy E, Robert MF, Pan L, Oligny L, Mitchell GA (2001) The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res 9:119\u2013128. https:\/\/doi.org\/10.1038\/oby.2001.15","journal-title":"Obes Res"},{"key":"950_CR47","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2147\/ndt.s208061","volume":"15","author":"H Xu","year":"2019","unstructured":"Xu H, Zhuang X (2019) Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review. Neuropsychiatr Dis Treat 15:2087\u20132099. https:\/\/doi.org\/10.2147\/ndt.s208061","journal-title":"Neuropsychiatr Dis Treat"},{"key":"950_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1124\/jpet.110.175539","volume":"338","author":"C Yang","year":"2011","unstructured":"Yang C, Chen Y, Tang L, Wang ZJ (2011) Haloperidol disrupts opioid-antinociceptive tolerance and physical dependence. J Pharmacol Exp Ther 338:164\u2013172. https:\/\/doi.org\/10.1124\/jpet.110.175539","journal-title":"J Pharmacol Exp Ther"},{"key":"950_CR49","doi-asserted-by":"publisher","first-page":"109732","DOI":"10.1016\/j.cellsig.2020.109732","volume":"75","author":"H Yang","year":"2020","unstructured":"Yang H, Shen H, Li J, Stanford KI, Guo LW (2020) Sigma-1 receptor ablation impedes adipocyte-like differentiation of mouse embryonic fibroblasts. Cell Signal 75:109732. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109732","journal-title":"Cell Signal"},{"key":"950_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000339066","volume":"30","author":"C Younce","year":"2012","unstructured":"Younce C, Kolattukudy P (2012) MCP-1 induced protein promotes adipogenesis via oxidative stress, endoplasmic reticulum stress and autophagy. Cell Physiol Biochem 30:307\u2013320. https:\/\/doi.org\/10.1159\/000339066","journal-title":"Cell Physiol Biochem"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-023-00950-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-023-00950-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-023-00950-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T01:05:41Z","timestamp":1687914341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-023-00950-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s13105-023-00950-8","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"type":"print","value":"1138-7548"},{"type":"electronic","value":"1877-8755"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal procedures were approved with code 12-1048-03-15, by the Animal Ethics Committee of the INSERM unit US006, CREFRE (Toulouse, France) or by the Committee for the Care and Use of Animals of the University of Salamanca (Spain).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}